Curaleaf Holdings (CURLF) Other Operating Expenses (2019 - 2026)
Curaleaf Holdings (CURLF) posted quarterly Other Operating Expenses of $43.3 million for Q1 2026, up 1272.69% year-over-year from $3.2 million in Q1 2025, and down 8.74% quarter-over-quarter from $47.5 million in Q4 2025.
Curaleaf Holdings (CURLF) Other Operating Expenses (2019 - 2026) Analysis & Trends
Curaleaf Holdings' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $43.3 million for Q1 2026.
- In Q1 2026, Other Operating Expenses rose 1272.69% year-over-year to $43.3 million; the TTM figure through Mar 2026 stood at $180.4 million (up 20.27% YoY), while the FY2025 annual figure was $177.1 million, down 10.31% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $43.3 million, down from $47.5 million in the prior quarter.
- The five-year high for Other Operating Expenses was $142.1 billion in Q4 2023, with the low at -$144.5 million in Q4 2022.
- The 5-year median for Other Operating Expenses is $43.4 million (2024), against an average of $8.9 billion.
- The sharpest annual moves came in 2022 and 2023: Other Operating Expenses slumped 6807.69% in 2022, then surged 98484.02% in 2023.
- Curaleaf Holdings' Other Operating Expenses stood at -$144.5 million in 2022, then soared by 98484.02% to $142.1 billion in 2023, then slumped by 99.95% to $65.3 million in 2024, then fell by 27.27% to $47.5 million in 2025, then fell by 8.74% to $43.3 million in 2026.
- Business Quant data shows CURLF's Other Operating Expenses at $43.3 million in Q1 2026, $47.5 million in Q4 2025, and $45.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.02 Mn |
| Mar 31, 2026 | 43.33 Mn |
| Dec 31, 2025 | 47.48 Mn |
| Sep 30, 2025 | 45.53 Mn |
| Jun 30, 2025 | 44.05 Mn |
| Mar 31, 2025 | -3.70 Mn |
| Dec 31, 2024 | 65.29 Mn |
| Sep 30, 2024 | 44.99 Mn |
| Jun 30, 2024 | 43.41 Mn |
| Mar 31, 2024 | 43.81 Mn |
| Dec 31, 2023 | 142.13 Bn |
| Sep 30, 2023 | -24.79 Mn |
| Jun 30, 2023 | 43.33 Mn |
| Dec 31, 2022 | -144.46 Mn |
| Sep 30, 2022 | 33.45 Mn |
| Jun 30, 2022 | 36.12 Mn |
| Mar 31, 2022 | -872,000.00 |
| Dec 31, 2021 | -8.90 Mn |
| Sep 30, 2021 | 1.32 Mn |
| Jun 30, 2021 | -753,000.00 |